 |
PDBsum entry 4gxu
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Viral protein/immune system
|
PDB id
|
|
|
|
4gxu
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
(+ 0 more)
325 a.a.
|
 |
|
|
|
|
|
|
|
(+ 0 more)
171 a.a.
|
 |
|
|
|
|
|
|
|
228 a.a.
|
 |
|
|
|
|
|
|
|
214 a.a.
|
 |
|
|
|
|
|
|
|
125 a.a.
|
 |
|
|
|
|
|
|
|
111 a.a.
|
 |
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Viral protein/immune system
|
 |
|
Title:
|
 |
Crystal structure of antibody 1f1 bound to the 1918 influenza hemagglutinin
|
|
Structure:
|
 |
Hemagglutinin ha1 chain. Chain: a, c, e, g, i, k. Fragment: unp residues 18-344. Synonym: hemagglutinin receptor binding subunit. Engineered: yes. Hemagglutinin ha2 chain. Chain: b, d, f, h, j, l. Fragment: unp residues 345-520. Synonym: hemagglutinin membrane fusion subunit.
|
|
Source:
|
 |
Influenza a virus. Organism_taxid: 88776. Strain: a/south carolina/1/1918 h1n1. Gene: ha. Expressed in: trichoplusia ni. Expression_system_taxid: 7111. Expression_system_cell_line: high5. Homo sapiens. Human.
|
|
Resolution:
|
 |
|
3.29Å
|
R-factor:
|
0.221
|
R-free:
|
0.255
|
|
|
Authors:
|
 |
D.C.Ekiert,I.A.Wilson
|
|
Key ref:
|
 |
T.Tsibane
et al.
(2012).
Influenza human monoclonal antibody 1F1 interacts with three major antigenic sites and residues mediating human receptor specificity in H1N1 viruses.
Plos Pathog,
8,
e1003067.
PubMed id:
|
 |
|
Date:
|
 |
|
04-Sep-12
|
Release date:
|
19-Dec-12
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q9WFX3
(HEMA_I18A0) -
Hemagglutinin from Influenza A virus (strain A/Brevig Mission/1/1918 H1N1)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
566 a.a.
325 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
Q9WFX3
(HEMA_I18A0) -
Hemagglutinin from Influenza A virus (strain A/Brevig Mission/1/1918 H1N1)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
566 a.a.
171 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
No UniProt id for this chain
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
No UniProt id for this chain
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Plos Pathog
8:e1003067
(2012)
|
|
PubMed id:
|
|
|
|
|
| |
|
Influenza human monoclonal antibody 1F1 interacts with three major antigenic sites and residues mediating human receptor specificity in H1N1 viruses.
|
|
T.Tsibane,
D.C.Ekiert,
J.C.Krause,
O.Martinez,
J.E.Crowe,
I.A.Wilson,
C.F.Basler.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Most monoclonal antibodies (mAbs) to the influenza A virus hemagglutinin (HA)
head domain exhibit very limited breadth of inhibitory activity due to antigenic
drift in field strains. However, mAb 1F1, isolated from a 1918 influenza
pandemic survivor, inhibits select human H1 viruses (1918, 1943, 1947, and 1977
isolates). The crystal structure of 1F1 in complex with the 1918 HA shows that
1F1 contacts residues that are classically defined as belonging to three
distinct antigenic sites, Sa, Sb and Ca(2). The 1F1 heavy chain also reaches
into the receptor binding site (RBS) and interacts with residues that contact
sialoglycan receptors and determine HA receptor specificity. The 1F1 epitope is
remarkably similar to the previously described murine HC63 H3 epitope, despite
significant sequence differences between H1 and H3 HAs. Both antibodies potently
inhibit receptor binding, but only HC63 can block the pH-induced conformational
changes in HA that drive membrane fusion. Contacts within the RBS suggested that
1F1 may be sensitive to changes that alter HA receptor binding activity.
Affinity assays confirmed that sequence changes that switch the HA to avian
receptor specificity affect binding of 1F1 and a mAb possessing a closely
related heavy chain, 1I20. To characterize 1F1 cross-reactivity, additional
escape mutant selection and site-directed mutagenesis were performed. Residues
190 and 227 in the 1F1 epitope were found to be critical for 1F1 reactivity
towards 1918, 1943 and 1977 HAs, as well as for 1I20 reactivity towards the 1918
HA. Therefore, 1F1 heavy-chain interactions with conserved RBS residues likely
contribute to its ability to inhibit divergent HAs.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
| | |